Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Recreation Days Held during Second National Polio Immunization Campaigns (2014)

 
Second National Immunization Campaign against Polio
 
During 15th -21st November 2014, the Second National Polio Immunization Campaign was implemented in collaboration with UNICEF and WHO,  through which a series of Polio Vaccination Recreation Days were planned covering different areas in Lebanon, including: Tripoli, Deir Ammar, Meniyeh Danniyeh, Bebnine, Baalbeck, Beirut, Saida and Iqlim El-Kharoub.
 
These Recreation Days achieved a greater success by reaching 96% of the Primary Health Care department's target in vaccinating children under 5 years old against polio, among which 45% of the total vaccinated children were Syrian and other nationalities.
Examples of the Recreation days held in November are:
 
Recreation Day at Riyadi Club, Beirut
On Monday, November 17th 2014 a successful Recreation Day was held for school children at Riyadi Club, Beirut. This event was organized by the Primary Health Care Department (MoPH) in collaboration with UNICEF, and attended by representatives from WHO and IMC.
During this day approximately 200 students, under the age of 5 years old, from the schools of Dar el Aytam el Islamiya and Al Makassed, were vaccinated under the supervision of Registered Nurses from Primary Health Care Centers of Dar el Fatwa, Makhzoumi Foundation, Al Makassed Charitable Society and Beirut Development Association Center.
In addition to the free polio vaccination, the participating children were entertained with clowns and lively plays performed by ‘’The Arab Puppet Theatre Foundation’’. At the end of the event, The Rotary Club distributed snacks and coloring books to the children.
 

Karakozian Primary Health Care Center
On Tuesday 18th November 2014, UNICEF conducted a documentary shooting session at Karakozian Primary Health Care Center concerning the Second National Immunization Campaign against Polio. The essential role the Ministry plays in preventing poliomyelitis disease through organizing such National Polio Vaccination Campaigns was reported. Furthermore, the proceeding of the campaign was presented and parents’ opinion regarding the campaign and the reason behind vaccinating their children was also highlighted.
 

Recreation Day at Ch’him
On Thursday, 20th November 2014 another successful Recreation Day was also held at Ch’him Educational Hall, which happened to take place simultaneously with the celebration of Lebanon’s Independence Day reflected in the attending children’s costumes and celebration spirit.
During this event, 958 children under the age of 5 years old were vaccinated against polio, attending from schools located in the region of ‘’Iqlim Kharoub’’. Out of a total of 42 private and public schools in this region, 17 schools participated, and out of 15 public schools, 8 schools attended this event.
Aside from the free polio vaccination, the children were also entertained with several activities, including: puppet shows, musical plays and songs. The children were also given coloring books and snacks at the end of the event by the Rotary Club.
 
    4
    ...
ATC Name B/G Ingredients Dosage Form Price
C09AA05 TRITACE B Ramipril - 10mg 10mg Tablet 689,391 L.L
N05AX13 TREVICTA B Paliperidone - 175mg 175mg Injectable suspension, prolonged release 35,006,953 L.L
N03AX11 TOPAMAX B Topiramate - 50mg 50mg Tablet, film coated 1,914,976 L.L
N05AX13 TREVICTA B Paliperidone - 263mg 263mg Injectable suspension, prolonged release 40,713,332 L.L
J05AH02 TAMIFLU B Oseltamivir (phosphate) - 75mg 75mg Capsule 1,464,788 L.L
N05AX13 TREVICTA B Paliperidone - 350mg 350mg Injectable suspension, prolonged release 50,113,800 L.L
J05AH02 TAMIFLU B Oseltamivir (phosphate) - 75mg 75mg Capsule 1,464,788 L.L
N05AX13 TREVICTA B Paliperidone - 525mg 525mg Injectable suspension, prolonged release 75,169,378 L.L
R05FA02 TUSCALMAN A B Noscapine HCl - 5mg, Guaifenesin - 25mg Suppository 624,963 L.L
R05FA02 TUSCALMAN B B Noscapine HCl - 10mg, Guaifenesin - 50mg Suppository 615,992 L.L
J06BB02 TETAGAM P BioHuman Human Tetanus Immunoglobulin - 250IU/ml 250IU/ml Injectable solution 3,075,475 L.L
J06BB02 TETANUS GAMMA BioHuman Human Tetanus Immunoglobulin - 250IU/ml 250IU/ml Injectable solution 3,077,399 L.L
H01AB01 THYROGEN BioHuman Thyrotropin alfa - 0.9mg 0.9mg Injectable lyophilised powder for solution+diluent 65,558,997 L.L
A10BJ05 TRULICITY BioTech Dulaglutide - 0.75mg/0.5ml 0.75mg/0.5ml Injectable solution 10,165,201 L.L
A10BJ05 TRULICITY BioTech Dulaglutide - 1.5mg/0.5ml 1.5mg/0.5ml Injectable solution 10,165,201 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution L.L
L04AA04 THYMOGLOBULINE 5mg/ml BioTech Rabbit anti-human thymocyte immunoglobulin - 25mg/5ml 25mg/5ml Injectable powder for solution 21,928,046 L.L
L01FD01 TRASTUREL BioTech Trastuzumab - 440mg L.L
L04AA23 TYSABRI BioTech Natalizumab - 300mg/15ml 300mg/15ml Injectable concentrated solution 126,830,594 L.L
A10AE04 TOUJEO BioTech Insulin glargine - 300Units/ml 300Units/ml Injectable solution 4,559,658 L.L
A10AE06 TRESIBA BioTech Insulin degludec - 100IU/ml 100IU/ml Injectable solution 6,857,628 L.L
L01FA01 TRUXIMA BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 31,102,895 L.L
L01FA01 TRUXIMA BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 69,144,591 L.L
L01FD01 TRASTUREL BioTech Trastuzumab - 440mg 440mg Injectable lyophilised powder 52,047,114 L.L
L01FD01 TRAZIMERA BioTech Trastuzumab - 440mg 440mg Injectable powder for solution+solvent 75,295,202 L.L
L01FD01 TRAZIMERA BioTech Trastuzumab - 150mg 150mg Injectable powder for solution 28,550,630 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1200mg 1200mg Injectable concentrate for solution 375,054,619 L.L
L01FF05 TECENTRIQ BioTech Atezolizumab - 1875mg/15ml 1875mg/15ml Injectable solution 375,054,619 L.L
L04AC13 TALTZ BioTech Ixekizumab - 80mg/ml 80mg/ml Injectable solution 85,080,792 L.L
    4
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025